Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW -1.22% slipped 1.67% to $116.96 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.25% rising 0.85% to 4,479.53 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.12% rising 0.61% to 35,335.71. The stock's fall snapped a two-day winning streak. Edwards Lifesciences Corp. closed $2.37 below its 52-week high ($119.33), which the company achieved on August 20th.
The stock underperformed when compared to some of its competitors Monday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT -5.15% fell 1.09% to $128.48, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX -1.29% fell 1.01% to $43.99, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI -1.66% fell 0.62% to $196.84. Trading volume (2.3 M) eclipsed its 50-day average volume of 2.3 M.